Seeing Is Believing
NBIX is currently covered by 24 analysts with an average price target of $171.42. This is a potential upside of $20.71 (13.74%) from yesterday's end of day stock price of $150.71.
Neurocrine Biosciences's activity chart (see below) currently has 288 price targets and 277 ratings on display. The stock rating distribution of NBIX is 39.47% HOLD and 60.53% BUY.
Analysts average stock forecasts to be materialized ratio is 84.26% with an average time for these price targets to be met of 270 days.
Highest price target for NBIX is $219, Lowest price target is $114, average price target is $171.42.
Most recent stock forecast was given by ASHWANI VERMA from UBS on 08-Jan-2025.
Currently out of the existing stock ratings of NBIX, 45 are a HOLD (39.47%), 69 are a BUY (60.53%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$162
$13.27 (8.92%)
$193
21 days ago
(08-Jan-2025)
3/5 (60%)
$23.03 (16.57%)
262
Buy
$160
$11.27 (7.58%)
$159
1 months 6 days ago
(23-Dec-2024)
11/14 (78.57%)
$25.8 (19.23%)
394
Buy
$165
$16.27 (10.94%)
$160
1 months 6 days ago
(23-Dec-2024)
7/11 (63.64%)
$30.8 (22.95%)
206
Buy
$190
$41.27 (27.75%)
$190
1 months 13 days ago
(16-Dec-2024)
13/19 (68.42%)
$56.21 (42.01%)
528
Buy
$148
$-0.73 (-0.49%)
$152
1 months 13 days ago
(16-Dec-2024)
11/11 (100%)
$14.21 (10.62%)
476
What is NBIX (Neurocrine Biosciences) average time for price targets to be met?
Which analyst has the current highest performing score on NBIX (Neurocrine Biosciences) with a proven track record?
Which analyst has the most public recommendations on NBIX (Neurocrine Biosciences)?
Which analyst is the currently most bullish on NBIX (Neurocrine Biosciences)?
Which analyst is the currently most reserved on NBIX (Neurocrine Biosciences)?